News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
conflict of interest
conflict of interest
Study: Hidden Conflicts of Interest Permeate Medicine
Diana Kwon | Jan 19, 2017
Three investigations reveal the influence of industry money in patient advocacy groups, treatment guidelines, and Twitter feeds.
Q&A: From FDA to Industry
Kerry Grens | Sep 27, 2016
Among a subset of US Food and Drug Administration regulators who leave the agency, more than half go to work for pharmaceutical companies, researchers report.
Study: Transparency Lacking in Biomedical Literature
Anna Azvolinsky | Jan 4, 2016
Few authors make their full data available and most published papers do not clearly state funding sources and conflicts of interest.
Using FOIA to Read Scientists’ Emails
Kerry Grens | Sep 8, 2015
Journalists and activists use the Freedom of Information Act to expose academics’ relationships with industry.
More Transparency in IRB-Industry Ties
Kerry Grens | Jul 13, 2015
Conflicts of interest among institutional review board members are disclosed more often than they were a decade ago, according to a survey of academics.
Climate Change Denier on Fossil Fuel Payroll
Bob Grant | Feb 23, 2015
A leading scientific voice among global warming skeptics received funding from the energy industry while publishing claims that climate change is not driven by human activity.
Lawsuit Claims Stem Cells Unsafe
Kerry Grens | Jul 18, 2014
A former employee complains that StemCells, Inc., fired him after he blew the whistle on improper manufacturing practices that could endanger patients.
Industry Funds Limit Freedom: Report
Kerry Grens | Nov 27, 2013
A report by a Canadian organization finds that industry-academia relationships compromise university investigators' liberty.
Opinion: Problems with Hidden COI
Philippe Grandjean | Oct 28, 2013
There may be much more to conflicts of interest than what gets declared.
Selling an Anthrax Scare?
Kate Yandell | May 21, 2013
A US government advisor warned officials of the dangers of antibiotic-resistant anthrax while profiting from antitoxin sales.